"10.1371_journal.pone.0148920","plos one","2016-02-16T00:00:00Z","Shia T Kent; Samantha G Bromfield; Greer A Burkholder; Louise Falzon; Suzanne Oparil; Edgar T Overton; Michael J Mugavero; Joseph E Schwartz; Daichi Shimbo; Paul Muntner","Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America; Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America; Center for Behavioral Cardiovascular Health, Department of Medicine, Columbia University Medical Center, New York, New York, United States of America; Department of Medicine, Vascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham, Alabama, United States of America; Applied Behavioral Medicine Research Institute, Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, United States of America","Conceived and designed the experiments: PM STK. Analyzed the data: STK. Performed systematic review of literature: STK SGB PM. Provided HIV expertise: GAB ETO MJM. Provided ABPM expertise: SO JES DS PM. Conducted literature database search: LF. Reviewed and edited manuscript: All authors.","S.T.K. has received salary support from Amgen. G.A.B. has received research support from Bristol-Myers Squibb and Amgen, and has consulted for Definicare, LLC. S.O. has received research support from AstraZeneca, Bayer Healthcare Pharmaceuticals, Merck and Co., Novartis, Daiichi Sankyo, Medtronic, and Arbor Pharmaceuticals, and was a consultant/advisory board member for AstraZeneca, Bayer, Daiichi Sankyo, Forest Laboratories, Novartis, and Takeda Global Research and Development. The remaining authors have no conflicts of interest. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2016","02","Shia T Kent","STK",10,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
